HMGCR and neoplasm: Simvastatin exerts its anti-tumor effects by inhibiting HMG-CoA reductase and blocking the mevalonate pathway, thereby affecting the activity of Ras and RhoGTAases. It may promote cell cycle arrest and apoptosis, thus playing an anti-tumor role